RD
Rajen Dhirubhai Shah
About Rajen Dhirubhai Shah
Data last updated:
Rajen Dhirubhai Shah is a Whole-Time Director at Raptim Research Private Limited (since 2004), Designated Partner at Citus Research Llp (since 2018) and Director at Nova Chemdrugs Private Limited (since 2001). The companies operate in Life Sciences, Healthcare and Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹172 Cr; the largest is Raptim Research Private Limited at ₹146 Cr (FY 2025). Earlier, Rajen Dhirubhai Shah was a Director at J B Chemicals And Pharmaceuticals Limited (2003–2013) and Director at Accela Pharmaceuticals Private Limited (2010–2022) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 29 Jun 2004 | 2002 | ₹146 Cr (FY 2025) | Active | |
| Designated Partner | 25 Sep 2018 | 2018 | ₹22.91 Cr (FY 2023) | Active | |
| Director | 06 Dec 2001 | 2001 | ₹3.09 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Aug 2003 | 1976 | ₹4,208 Cr (FY 2026) | Active | |
| Director | 10 Nov 2010 | 2010 | ₹10 Lakh (FY 2023) | Active | |
| Director | 11 Mar 2001 | 1998 | ₹70,420 (FY 2016) | Strike Off | |
| Director | 01 Dec 2001 | 1993 | ₹8.8 Lakh (FY 2022) | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajen Dhirubhai Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Meghana Rajen Shah | 10377931 | Raptim Research Private Limited , Nova Chemdrugs Private Limited | Director |
| Viraj Dhirubhai Shah | 02579881 | Raptim Research Private Limited , Citus Research Llp and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajen Dhirubhai Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajen Dhirubhai Shah
Rajen Dhirubhai Shah currently holds 3 directorships: Raptim Research Private Limited (Whole-Time Director, since 29 Jun 2004, revenue ₹146 Cr (FY 2025)); Citus Research Llp (Designated Partner, since 25 Sep 2018, revenue ₹22.91 Cr (FY 2023)); Nova Chemdrugs Private Limited (Director, since 06 Dec 2001, revenue ₹3.09 Cr (FY 2025)).
Rajen Dhirubhai Shah was first appointed on 11 Mar 2001 as Director at Nova Containers Limited. The most recent appointment on record is 25 Sep 2018 at Citus Research Llp.
The 3 current companies of Rajen Dhirubhai Shah that report revenue have a combined latest revenue of ₹172 Cr: Raptim Research Private Limited ₹146 Cr (FY 2025); Citus Research Llp ₹22.91 Cr (FY 2023); Nova Chemdrugs Private Limited ₹3.09 Cr (FY 2025).
Rajen Dhirubhai Shah held 4 earlier board appointments: J B Chemicals And Pharmaceuticals Limited (Director, 01 Aug 2003 to 15 Apr 2013); Accela Pharmaceuticals Private Limited (Director, 10 Nov 2010 to 19 Apr 2022); Nova Containers Limited (Director, 11 Mar 2001 to 13 Oct 2015); Nova Machineries Private Limited (Director, 01 Dec 2001 to 01 Mar 2016).
The current boards of Rajen Dhirubhai Shah's companies include Meghana Rajen Shah (Raptim Research Private Limited), Viraj Dhirubhai Shah (Raptim Research Private Limited).